Group behaviour therapy programmes for smoking cessation
نویسندگان
چکیده
منابع مشابه
Group behaviour therapy programmes for smoking cessation.
BACKGROUND Group therapy offers individuals the opportunity to learn behavioural techniques for smoking cessation, and to provide each other with mutual support. OBJECTIVES To determine the effect of group-delivered behavioural interventions in achieving long-term smoking cessation. SEARCH METHODS We searched the Cochrane Tobacco Addiction Group Specialized Register, using the terms 'behavi...
متن کاملSmoking Cessation with Medication and Behaviour Therapy
Background and Objective Smoking Cessation Clinics (SCCs) involve the use of cognitive behavior therapy and effective medications provided by specialists. Our objective was to report socio-demographic data, investigative services provided, and determine the smoking cessation success. Methods Data from all hospitals affiliated with the Beyoglu Public Hospitals Union were obtained between Janua...
متن کاملNicotine replacement therapy for smoking cessation.
BACKGROUND The aim of nicotine replacement therapy (NRT) is to temporarily replace much of the nicotine from cigarettes to reduce motivation to smoke and nicotine withdrawal symptoms, thus easing the transition from cigarette smoking to complete abstinence. OBJECTIVES The aims of this review were: To determine the effect of NRT compared to placebo in aiding smoking cessation, and to consider ...
متن کاملThe search for individualized smoking cessation therapy
1. Disciplina de Pneumologia, Universidade Federal de São Paulo, São Paulo (SP) Brasil. Although the prevalence of smoking in Brazil has been decreasing in recent decades,(1) tobacco is a drug classified as licit; therefore, the epidemic of this neurobehavioral disease, caused by nicotine dependence, will probably endure for many decades to come.(2) As with any epidemic, it is necessary to unde...
متن کاملSmoking cessation therapy with varenicline
Smoking cessation is the only available intervention proven to halt progression of chronic obstructive pulmonary disease (COPD). The authors discuss the current existing treatment modalities and the role of a newly approved agent, varenicline, in promotion of smoking cessation. Varenicline is a novel agent that is a centrally acting partial nicotinic acetylcholine receptor agonist. It has both ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2017
ISSN: 1465-1858
DOI: 10.1002/14651858.cd001007.pub3